In a study using CL1–5 human lung adenocarcinoma cells, the reduction in O‐GlcNAcylation caused by treatment with the GFAT inhibitor DON was shown to reduce OGA gene and protein expression levels [34]. This evidence concerns the gene GFPT1 and lung adenocarcinoma.